Tobacco

NIDA Director outlines potential risks to people who smoke and use drugs during COVID-19 pandemic

The precarious intersection of the COVID-19 national health emergency and the concurrent epidemic of drug overdose deaths is outlined in the Annals of Internal Medicine this week by Dr. Nora D. Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

E-Cigarette Characteristics May Influence Use and Are Potential Targets for Regulatory Policy

People's decisions to use e-cigarettes, as well as perceptions about associated risks, are influenced by the e-cigarettes' nicotine levels and available flavors. The influence of these characteristics on decision-making and perceived risk differs between people who smoke cigarettes and people who do not smoke.
Subscribe to Tobacco